438

Compound name
Ribociclib
Alt Name
LEE011
LEE-011
Compound Image
Ribociclib.png
SMILES
CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5
MW
434.50
Brutto
C23H30N8O
InChI
InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)
InChI Key
RHXHGRAEPCAFML-UHFFFAOYSA-N
Approval Jurisdiction
2017 FDA 2017 EMA
Approved for clinical use
Advanced (Metastatic) Breast Cancer HR+, HER2-Ve
CAS
1211441-98-3
PubChem CID
44631912
Action
CDK4/6
Approved Drug List
1
Commercial Vendor
Novartis